XML 122 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation
12 Months Ended
Dec. 31, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-Based Compensation
  NOTE 17   Stock-Based Compensation

 

As part of its employee and director compensation programs, the Company may grant certain stock awards under the provisions of the existing stock compensation plans, including plans assumed in acquisitions. The plans provide for grants of options to purchase shares of common stock at a fixed price equal to the fair value of the underlying stock at the date of grant. Option grants are generally exercisable up to ten years from the date of grant. In addition, the plans provide for grants of shares of common stock or stock units that are subject to restriction on transfer prior to vesting. Most stock and unit awards vest over three to five years and are subject to forfeiture if certain vesting requirements are not met. Stock incentive plans of acquired companies are generally terminated at the merger closing dates. Participants under such plans receive the Company’s common stock, or options to buy the Company’s stock, based on the conversion terms of the various merger agreements. At December 31, 2013, there were 54 million shares (subject to adjustment for forfeitures) available for grant under various plans.

 

Stock Option Awards

The following is a summary of stock options outstanding and exercised under various stock option plans of the Company:

 

Year Ended December 31   Stock
Options/Shares
     Weighted-
Average
Exercise Price
       Weighted-Average
Remaining Contractual
Term
       Aggregate
Intrinsic Value
(in millions)
 

2013

              

Number outstanding at beginning of period

    63,171,918       $ 28.83             

Granted

    1,168,011         33.99             

Exercised

    (17,260,740      28.41             

Cancelled (a)

    (354,424      29.22                         

Number outstanding at end of period (b)

    46,724,765       $ 29.12           4.4         $ 527   

Exercisable at end of period

    39,556,000       $ 29.19           3.8         $ 444   

2012

              

Number outstanding at beginning of period

    75,823,941       $ 27.60             

Granted

    4,180,492         28.65             

Exercised

    (15,681,323      23.12             

Cancelled (a)

    (1,151,192      24.90                         

Number outstanding at end of period (b)

    63,171,918       $ 28.83           4.9         $ 196   

Exercisable at end of period

    50,671,654       $ 30.12           4.2         $ 92   

2011

              

Number outstanding at beginning of period

    85,622,705       $ 26.80             

Granted

    4,063,369         28.66             

Exercised

    (8,508,107      19.49             

Cancelled (a)

    (5,354,026      28.44                         

Number outstanding at end of period (b)

    75,823,941       $ 27.60           5.2         $ (42

Exercisable at end of period

    57,039,334       $ 29.14           4.4         $ (120

 

(a) Options cancelled include both non-vested (i.e., forfeitures) and vested options.
(b) Outstanding options include stock-based awards that may be forfeited in future periods. The impact of the estimated forfeitures is reflected in compensation expense.

Stock-based compensation expense is based on the estimated fair value of the award at the date of grant or modification. The fair value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model, requiring the use of subjective assumptions. Because employee stock options have characteristics that differ from those of traded options, including vesting provisions and trading limitations that impact their liquidity, the determined value used to measure compensation expense may vary from their actual fair value. The following table includes the weighted average estimated fair value and assumptions utilized by the Company for newly issued grants:

 

Year Ended December 31   2013      2012      2011  

Estimated fair value

  $ 12.13       $ 10.19       $ 10.55   

Risk-free interest rates

    1.0      .9      2.5

Dividend yield

    2.6      2.6      2.5

Stock volatility factor

    .49         .49         .47   

Expected life of options (in years)

    5.5         5.5         5.5   

 

Expected stock volatility is based on several factors including the historical volatility of the Company’s stock, implied volatility determined from traded options and other factors. The Company uses historical data to estimate option exercises and employee terminations to estimate the expected life of options. The risk-free interest rate for the expected life of the options is based on the U.S. Treasury yield curve in effect on the date of grant. The expected dividend yield is based on the Company’s expected dividend yield over the life of the options.

 

The following summarizes certain stock option activity of the Company:

 

Year Ended December 31 (Dollars in Millions)   2013      2012      2011  

Fair value of options vested

  $ 41       $ 49       $ 54   

Intrinsic value of options exercised

    144         143         61   

Cash received from options exercised

    489         362         165   

Tax benefit realized from options exercised

    56         75         23   

To satisfy option exercises, the Company predominantly uses treasury stock.

Additional information regarding stock options outstanding as of December 31, 2013, is as follows:

 

    Outstanding Options      Exercisable Options  
Range of Exercise Prices   Shares        Weighted-
Average
Remaining
Contractual
Life (Years)
       Weighted-
Average
Exercise
Price
             Shares        Weighted-
Average
Exercise
Price
 

$11.02 – $15.00

    4,661,087           5.1         $ 11.39                4,661,087         $ 11.40   

$15.01 – $20.00

    167,391           2.4           19.54                167,391           19.54   

$20.01 – $25.00

    3,390,179           6.2           23.85                2,216,001           23.84   

$25.01 – $30.00

    13,108,918           5.2           29.05                8,276,837           29.29   

$30.01 – $35.00

    17,999,955           3.9           31.97                16,837,858           31.83   

$35.01 – $36.25

    7,397,235           3.1           36.07                7,396,826           36.07   

Total

    46,724,765           4.4         $ 29.12                39,556,000         $ 29.19   

Restricted Stock and Unit Awards

A summary of the status of the Company’s restricted shares of stock and unit awards is presented below:

 

    2013    2012           2011  
Year Ended December 31   Shares      Weighted-
Average Grant-
Date Fair Value
          Shares      Weighted-
Average Grant-
Date Fair Value
          Shares      Weighted-
Average Grant-
Date Fair Value
 

Nonvested Shares

                        

Outstanding at beginning of period

    8,935,743       $ 25.04             8,995,295       $ 22.46             8,811,027       $ 19.74   

Granted

    3,717,635         33.88             3,085,077         28.70             3,136,086         28.20   

Vested

    (3,744,411      22.17             (2,931,820      20.97             (2,552,979      20.15   

Cancelled

    (255,108      29.18             (212,809      25.01             (398,839      22.20   

Outstanding at end of period

    8,653,859      $ 29.96             8,935,743       $ 25.04             8,995,295       $ 22.46   

 

The total fair value of shares vested was $127 million, $86 million and $72 million for the years ended December 31, 2013, 2012 and 2011, respectively. Stock-based compensation expense was $129 million, $129 million and $118 million for the years ended December 31, 2013, 2012 and 2011, respectively. On an after-tax basis, stock-based compensation was $80 million, $80 million and $73 million for the years ended December 31, 2013, 2012 and 2011, respectively. As of December 31, 2013, there was $142 million of total unrecognized compensation cost related to nonvested share-based arrangements granted under the plans. That cost is expected to be recognized over a weighted-average period of 2.4 years as compensation expense.